Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,257 | 63 | 99.8% |
| Education | $5.11 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $438.49 | 11 | $0 (2020) |
| AbbVie, Inc. | $336.91 | 16 | $0 (2018) |
| Lilly USA, LLC | $218.04 | 2 | $0 (2023) |
| Allergan Inc. | $186.75 | 5 | $0 (2018) |
| Shire North American Group Inc | $182.65 | 5 | $0 (2018) |
| Amgen Inc. | $130.70 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $124.80 | 1 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $117.67 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $115.27 | 7 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $96.58 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $95.17 | 1 | Lilly USA, LLC ($95.17) |
| 2020 | $31.05 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($31.05) |
| 2018 | $713.40 | 9 | AbbVie, Inc. ($227.85) |
| 2017 | $1,423 | 53 | Boehringer Ingelheim Pharmaceuticals, Inc. ($316.32) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: Endocrinology | ||||||
| 02/28/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: DIABETES | ||||||
| 02/24/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: DIABETES | ||||||
| 02/23/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $89.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/22/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $78.88 | General |
| Category: DIABETES | ||||||
| 02/22/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/16/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: DIABETES | ||||||
| 02/16/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: DIABETES | ||||||
| 02/08/2017 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/06/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: Endocrinology | ||||||
| 01/31/2017 | AbbVie, Inc. | Viekira (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Virology | ||||||
| 01/31/2017 | AbbVie, Inc. | Viekira (Drug) | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: Virology | ||||||
| 01/31/2017 | AbbVie, Inc. | Viekira (Drug) | Food and Beverage | In-kind items and services | $1.61 | General |
| Category: Virology | ||||||
| 01/20/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: DIABETES | ||||||
About Dr. Sripathi Karanth, M.D
Dr. Sripathi Karanth, M.D is a Gastroenterology healthcare provider based in Woonsocket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124077300.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sripathi Karanth, M.D has received a total of $2,262 in payments from pharmaceutical and medical device companies, with $95.17 received in 2023. These payments were reported across 64 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,257).
Practice Information
- Specialty Gastroenterology
- Location Woonsocket, RI
- Active Since 05/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1124077300
Products in Payments
- JARDIANCE (Drug) $510.16
- VIBERZI (Drug) $153.49
- Prolia (Biological) $130.70
- DALIRESP (Drug) $124.80
- ARALAST (Biological) $123.87
- TRULICITY (Drug) $122.87
- Livalo (Drug) $117.67
- ZEPATIER (Drug) $115.27
- LINZESS (Drug) $96.01
- ELIQUIS (Drug) $89.88
- XARELTO (Drug) $82.98
- GATTEX (Drug) $58.78
- Creon (Drug) $58.11
- TOUJEO (Drug) $54.15
- Viekira (Drug) $41.87
- STELARA (Biological) $26.56
- XIFAXAN (Drug) $26.08
- Trintellix (Drug) $24.52
- TRADJENTA (Drug) $18.39
- Trulance (Drug) $15.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.